Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
9,34 SEK | -1,68% |
|
+6,99% | +177,15% |
17/06 | Transcript : Ascelia Pharma AB - Special Call | |
21/05 | Transcript : Ascelia Pharma AB, Q1 2024 Earnings Call, May 21, 2024 |
Vakgebied
Aantal werknemers: 13
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 49 | 01-01-14 | |
Director of Finance/CFO | 52 | 01-01-20 | |
Chief Tech/Sci/R&D Officer | 40 | 01-01-22 | |
Carin Linde
CTO | Chief Tech/Sci/R&D Officer | 52 | 01-01-19 |
Andreas Norlin
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-01-20 |
Marie Källström
LAW | General Counsel | 58 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 69 | 01-06-17 | |
Niels Mengel
BRD | Director/Board Member | 76 | 01-01-00 |
Director/Board Member | 59 | 01-01-17 | |
Hans Maier
BRD | Director/Board Member | 69 | 01-01-17 |
Lauren Barnes
BRD | Director/Board Member | 50 | 06-05-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 1 113 431 | 0 | 0 | 74,64 % |
Aandeel B | 1 | 33 757 746 | 26 026 327 ( 77,10 %) | 0 |
Bedrijfsgegevens
![Adres Ascelia Pharma AB(ACE)](https://cdn.zonebourse.com/static/address/55886696.png)
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+177,15% | 29,97 mln. | |
+38,36% | 52,73 mld. | |
+36,73% | 39 mld. | |
-8,63% | 38,52 mld. | |
+25,46% | 30,38 mld. | |
-11,17% | 26,39 mld. | |
+11,44% | 26,08 mld. | |
+45,09% | 14,15 mld. | |
+32,93% | 12,6 mld. | |
-5,30% | 11,51 mld. |